Neuland Laboratories receives EIR from USFDA for Bonthapally facility

30 Aug 2019 Evaluate

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Bonthapally, Hyderabad. The facility was inspected from June 17, 2019 to June 21, 2019.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Neuland Laboratories Share Price

1187.80 9.60 (0.81%)
Jul 01, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 826.70
Cipla 950.10
Dr. Reddy's Lab 4384.35
Aurobindo Pharma 522.55
Lupin 628.55
View more..